PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis Aug 4, 2021
Mountain Valley MD Announces Results From Cold Chain Storage Evaluation of Novel Quicksome™ Technology Jul 7, 2021
The Latest On Psybio Therapeutics: CEO Evan Levine Comments On Maxim Group Buy Rating, European Research, And More Jul 6, 2021
Mountain Valley MD Provides Update on Key Strategic Initiatives: Patent Award, FDA Collaborative Research Agreement,… Jun 24, 2021
Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004 Jun 24, 2021
PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Infectious Diseases Including COVID-19 Jun 22, 2021
PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression Jun 15, 2021